These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 16950701

  • 1. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
    Rössle M, Siegerstetter V, Euringer W, Olschewski M, Kromeier J, Kurz K, Langer M.
    Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
    [Abstract] [Full Text] [Related]

  • 2. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.
    Hernández-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, García-Pagán JC.
    Hepatology; 2004 Nov; 40(5):1197-202. PubMed ID: 15486923
    [Abstract] [Full Text] [Related]

  • 3. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J, Ripoll C, Bañares R, Echenagusia A, Catalina MV, Camúñez F, Simó G, Santos L.
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
    Darwish Murad S, Luong TK, Pattynama PM, Hansen BE, van Buuren HR, Janssen HL.
    Liver Int; 2008 Feb; 28(2):249-56. PubMed ID: 18251982
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I, Kelekis DA, Karatza C, Nikolaou V, Mouyia V, Brountzos EN.
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
    Cejna M, Peck-Radosavljevic M, Thurnher S, Schoder M, Rand T, Angermayr B, Lammer J.
    Cardiovasc Intervent Radiol; 2002 Sep; 25(5):365-72. PubMed ID: 11981612
    [Abstract] [Full Text] [Related]

  • 9. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents.
    Gandini R, Konda D, Simonetti G.
    Radiology; 2006 Oct; 241(1):298-305. PubMed ID: 16908675
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts.
    Jung HS, Kalva SP, Greenfield AJ, Waltman AC, Walker TG, Athanasoulis CA, Wicky ST.
    J Vasc Interv Radiol; 2009 Feb; 20(2):180-5. PubMed ID: 19097918
    [Abstract] [Full Text] [Related]

  • 12. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience.
    Rossi P, Salvatori FM, Fanelli F, Bezzi M, Rossi M, Marcelli G, Pepino D, Riggio O, Passariello R.
    Radiology; 2004 Jun; 231(3):820-30. PubMed ID: 15118117
    [Abstract] [Full Text] [Related]

  • 13. Multidetector-row computed tomography in the evaluation of transjugular intrahepatic portosystemic shunt performed with expanded-polytetrafluoroethylene-covered stent-graft.
    Fanelli F, Bezzi M, Bruni A, Corona M, Boatta E, Lucatelli P, Passariello R.
    Cardiovasc Intervent Radiol; 2011 Feb; 34(1):100-5. PubMed ID: 20532776
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
    Attwell A, Ludkowski M, Nash R, Kugelmas M.
    Aliment Pharmacol Ther; 2004 Oct 15; 20(8):867-73. PubMed ID: 15479358
    [Abstract] [Full Text] [Related]

  • 15. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt.
    Rössle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D.
    Surgery; 2004 Apr 15; 135(4):394-403. PubMed ID: 15041963
    [Abstract] [Full Text] [Related]

  • 16. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
    Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, Khalaf HA.
    J Gastroenterol Hepatol; 2005 Oct 15; 20(10):1494-502. PubMed ID: 16174064
    [Abstract] [Full Text] [Related]

  • 17. Intravascular ultrasound-guided direct intrahepatic portacaval shunt: midterm follow-up.
    Petersen B, Binkert C.
    J Vasc Interv Radiol; 2004 Sep 15; 15(9):927-38. PubMed ID: 15361560
    [Abstract] [Full Text] [Related]

  • 18. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE.
    N Engl J Med; 1995 May 04; 332(18):1192-7. PubMed ID: 7700312
    [Abstract] [Full Text] [Related]

  • 19. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 May 04; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 20. Stent graft in TIPS: technical and procedural aspects.
    Fanelli F, Salvatori FM, Corona M, Bruni A, Pucci A, Boatta E, Dominelli V, Conchiglia A, Passariello R.
    Radiol Med; 2006 Aug 04; 111(5):709-23. PubMed ID: 16791461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.